期刊文献+

治疗药物监测在低蛋白血症患者应用伏立康唑致肝损伤病例分析中的作用 被引量:2

Role of therapeutic drug monitoring in liver injury caused by voriconazole in patients with hypoproteinemia
下载PDF
导出
摘要 治疗药物监测在临床诊疗实践中发挥着越来越重要的作用。本文通过临床药师参与1例行异基因造血干细胞移植后低蛋白血症并肺部感染的患者应用伏立康唑抗真菌的治疗,监测伏立康唑血药浓度,分析确定肝损伤不良反应发生的原因为伏立康唑导致的药物性肝损伤。药师建议及时停药,医师采纳,患者不良反应逐渐好转,避免了伏立康唑对肝脏的进一步损伤,对保障患者安全用药具有一定意义。 Therapeutic drug monitoring plays an increasingly important role in clinical practice.In this article,a clinical pharmacist participated in the anti-fungal treatment with voriconazole for a patient with hypoproteinemia and lung infection after allogeneic hematopoietic stem cell transplantation.By monitoring the plasma concentration of voriconazole,the pharmacist identified the causes of adverse reactions to liver injury. The physician adopted the pharmacist's suggestion and end voriconazole use timely.The patient's adverse reaction was gradually eased,and further damage to the liver caused by voriconazole was avoided.
作者 冯婷婷 胡梦笛 李琴 范国荣 FENG Ting-ting;HU Meng-di;LI Qin;FAN Guo-rong(Department of CliniealPharmacy,Shanghai General Hospital Shanghai Jiao Tong University,Shanghai 200080;School of Medicine,Shanghai Jiao Tong University, Shanghai 200025;Shanghai Key Laboratoryfor Pharmaceutical Metabolite Research,Shanghai 200433)
出处 《中南药学》 CAS 2018年第12期1674-1676,共3页 Central South Pharmacy
基金 上海市卫计委重要薄弱学科建设--临床药学(No.2016ZB0302)
关键词 伏立康唑 治疗药物监测 肝损伤 不良反应 voriconazole therapeutic drug monitoring liver injury adverse reaction
  • 相关文献

参考文献8

二级参考文献152

  • 1姜英杰,李瑜元,聂玉强,王红,沙卫红.雷贝拉唑根除幽门螺杆菌疗效及其与CYP2C19基因多态性的关系[J].广州医学院学报,2004,32(3):22-25. 被引量:22
  • 2吴敏良,吴晓虹,陈枢青.细胞色素P450 2C19在中国汉族人群不同组织中的分布差异研究[J].中国药学杂志,2005,40(3):215-218. 被引量:5
  • 3Dimitrios I,Zonios,Juan GB,et al.Hallucinations duffng voficonazole therapy[J].Clinical Infectious Diseases,2008,47(1):e7-e10.
  • 4Sotirios T,Rodesa Z,Efthymia K,et al.painful peripheral neuropathy asoeiated with vorieonazole use[J].Arch Neurol,2005,62(1):144-146.
  • 5Aksoy F,Akdogan E,Aydin K,et al.Voriconazole-induced neuropathy[J].Chemotherapy,2008,54(3):224-227.
  • 6Miller DD,Cowen EW,Nguyen JC,et al.Melanoma associated with longterm voriconazole therapy:a new manifestation ofchronic photosensitivity[J].Arch Dermatol,2010,146(3):300-304.
  • 7Malani AN,Aronoff DM.Vorieonazole-induced photosensitivity[J].Clin,Med.Res,Sep 2008,6(2):83-85.
  • 8Scrap G,Serdar O,Gtiler D,et al.ArIgio-oedema as all anusual tolerable side effect of vorieonazole therapy[J].J.Med.Microbiol,Aug 2008,57(8):1 028-1 031.
  • 9Schaifer-Korting M. New systemic antifungal drugs: mechanisms of action, drug interactions and side effects [J]. Mycoses, 2003, 46(Suppl 1):28-31.
  • 10Wood N, Tan K, Purkins L, et al. Effect of omeprazole on the steady-state pharmacokinetics of voriconazole [ J ]. Br J Clin Pharmacol, 2003, 56(Suppl 1) :56-61.

共引文献129

同被引文献30

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部